
Lower respiratory tract infections are the major cause of death due to infectious disease in the developed and developing zzso Despite substantial progress in defining pathogens and in therapeutic options, there continues to be major controversies in the clinical management of these zzso This report reviews the guidelines for zzso pneumonia from the zzso Diseases Society of America zzso updated from the initial zzso Diagnosis should include a chest X-ray to differentiate acute zzso from zzso The decision for hospitalization should be based on social factors and evaluation of severity of zzso Identification of an zzso agent for zzso should include two zzso cultures, one zzso zzso zzso with seriously ill patients requiring studies for zzso zzso zzso for zzso treatment of zzso are zzso a zzso or a zzso zzso for zzso treatment of hospitalized patients are a zzso plus a zzso or a zzso zzso zzso for zzso patients are a zzso combined with either a zzso or a zzso While concern has arisen about increasing resistance to zzso arguments in favor of these agents include the fact that they have good in zzso activity against nearly all zzso pathogens except some zzso Clinical trials have shown zzso or superiority compared to other standard zzso They are well zzso and can be administered zzso or orally, once zzso A recent retrospective review has shown superior outcome with zzso treatment compared to zzso including a zzso reduction in zzso 

